Market Cap | 98.84M | P/E | - | EPS this Y | 46.60% | Ern Qtrly Grth | - |
Income | -36.16M | Forward P/E | -2.95 | EPS next Y | 22.30% | 50D Avg Chg | -6.00% |
Sales | 19.15M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -14.00% |
Dividend | N/A | Price/Book | 1.33 | EPS next 5Y | - | 52W High Chg | -50.00% |
Recommedations | 1.70 | Quick Ratio | 1.90 | Shares Outstanding | 30.03M | 52W Low Chg | 18.00% |
Insider Own | 14.28% | ROA | -33.26% | Shares Float | 24.29M | Beta | 1.47 |
Inst Own | 27.33% | ROE | -69.37% | Shares Shorted/Prior | 1.75M/1.62M | Price | 3.69 |
Gross Margin | 55.03% | Profit Margin | -265.33% | Avg. Volume | 113,364 | Target Price | 3.83 |
Oper. Margin | -258.85% | Earnings Date | Oct 31 | Volume | 197,335 | Change | 0.27% |
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Stifel | Buy | Apr 1, 24 |
Alliance Global Partners | Buy | Aug 11, 23 |
Stifel | Buy | Jul 25, 23 |
Craig-Hallum | Buy | May 12, 23 |
Alliance Global Partners | Buy | Nov 16, 22 |
Aegis Capital | Buy | Aug 18, 22 |
Cowen & Co. | Outperform | Aug 16, 22 |
Aegis Capital | Buy | May 16, 22 |
Cowen & Co. | Outperform | May 16, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Raphael Erez | Chief Executive Offi.. Chief Executive Officer | Jan 13 | Sell | 6.2075 | 1,200 | 7,449 | 1,112,059 | 01/18/23 |
Raphael Erez | Chief Executive Offi.. Chief Executive Officer | Nov 05 | Sell | 19.06 | 1,000 | 19,060 | 838,259 | 11/09/21 |
Raphael Erez | Chief Executive Offi.. Chief Executive Officer | Nov 03 | Sell | 18.73 | 38,340 | 718,108 | 839,259 | 11/05/21 |